TABLE 1.

Differentially expressed microRNAs for cholangiocarcinoma vs normal bile duct

MicroRNA	Fold change	p value
Overexpressed microRNAs
hsa-miR-21	2.57	3.65E – 07
hsa-miR-135b	1.98	3.63E – 06
hsa-miR-122	1.94	2.30E – 03
hsa-miR-27a	1.87	3.76E – 05
hsa-miR-29a	1.60	1.35E – 06
hsa-miR-429	1.49	5.82E – 03
hsa-miR-24	1.47	4.25E – 05
hsa-miR-203	1.45	1.63E – 04
hsa-miR-106b	1.45	2.48E – 05
hsa-miR-29b	1.41	7.29E – 05
hsa-miR-20a + hsa-miR-20b	1.40	1.61E – 03
hsa-miR-93	1.40	6.45E – 05
hsa-miR-30e	1.40	5.93E – 03
hsa-miR-30b	1.40	1.25E – 03
hsa-miR-151-3p	1.39	4.09E – 05
hsa-miR-10a	1.37	9.99E – 04
hsa-miR-181a	1.33	6.81E – 05
hsa-miR-96	1.32	3.24E – 04
hsa-miR-663b	1.31	5.01E – 03
hsa-miR-103	1.31	3.01E – 03
hsa-miR-221	1.29	3.52E – 03
hsa-miR-22	1.28	1.68E – 03
hsa-miR-107	1.28	2.35E – 03
hsa-miR-424	1.23	2.51E – 03
hsa-miR-340	1.19	2.29E – 04
Underexpressed microRNAs
hsa-miR-451	0.38	6.94E – 05
hsa-miR-145	0.49	1.88E – 05
hsa-miR-99a	0.52	3.69E – 06
hsa-miR-125b	0.53	1.55E – 05
hsa-miR-630	0.56	2.66E – 03
hsa-let-7c	0.63	1.50E – 03
hsa-miR-144	0.64	3.99E – 04
hsa-miR-100	0.67	6.36E – 04
hsa-miR-127-3p	0.69	8.89E – 04
hsa-miR-139-5p	0.72	2.75E – 03
hsa-miR-337-3p	0.74	3.21E – 04
hsa-miR-1	0.74	4.93E – 03
hsa-miR-126	0.76	4.69E – 03
hsa-miR-376c	0.80	8.33E – 03
hsa-miR-517c + hsa-miR-519a	0.80	4.74E – 04
hsa-miR-520e	0.82	7.83E – 03